Ediz S. Calay

2.3k total citations · 1 hit paper
17 papers, 1.8k citations indexed

About

Ediz S. Calay is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Ediz S. Calay has authored 17 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Ediz S. Calay's work include Endoplasmic Reticulum Stress and Disease (3 papers), Pancreatic function and diabetes (3 papers) and Adipose Tissue and Metabolism (2 papers). Ediz S. Calay is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (3 papers), Pancreatic function and diabetes (3 papers) and Adipose Tissue and Metabolism (2 papers). Ediz S. Calay collaborates with scholars based in United States, Israel and Germany. Ediz S. Calay's co-authors include Gökhan S. Hotamışlıgil, Ling Yang, Suneng Fu, Ping Li, Abdullah Yalçın, Gürol Tuncman, Amir Tirosh, Ryan C. Kunz, Karen Inouye and Kosei Eguchi and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

Ediz S. Calay

17 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance

2010 1.0k citations Ling Yang, Ping Li et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Ediz S. Calay

Since Specialization

Citations

This map shows the geographic impact of Ediz S. Calay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ediz S. Calay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ediz S. Calay more than expected).

Fields of papers citing papers by Ediz S. Calay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ediz S. Calay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ediz S. Calay. The network helps show where Ediz S. Calay may publish in the future.

Co-authorship network of co-authors of Ediz S. Calay

This figure shows the co-authorship network connecting the top 25 collaborators of Ediz S. Calay. A scholar is included among the top collaborators of Ediz S. Calay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ediz S. Calay. Ediz S. Calay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), K. Raja, Tomi Jun, Meng Ma, Tao Wang, Lei Ai, Ediz S. Calay, William Oh, Eric E. Schadt, (unknown)	1
2	Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records 2024 ·PLoS ONE ·Christopher F. Bell, Daniel C. Gibbons, (unknown), (unknown), (unknown), Vishal Patel, (unknown), (unknown), Ediz S. Calay, Arjun Puranik, Tyler Wagner, John C. O’Horo, Raymund R. Razonable	4
3	Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation 2024 ·PubMed Central ·(unknown), Zongzhi Liu, (unknown), Tomi Jun, Meng Ma, Tongyu Wang, Lei Ai, Ediz S. Calay, William Oh, Gustavo Stolovitzky, Eric E. Schadt, Xiaoyan Wang	2
4	THU-135 Real-world study of reasons for non-utilization of second-line treatment in patients with primary biliary cholangitis 2024 ·Journal of Hepatology ·Seema Meloni, Claudia O. Zein, (unknown), (unknown), Ediz S. Calay, Tyler Wagner, (unknown), (unknown), Olivier Gattolliat, (unknown), Brian D. Juran, Konstantinos N. Lazaridis	2
5	Real-World Treatment Outcomes of Teclistamab Under an Outpatient Model for Step-up Dosing Administration 2023 ·Blood ·(unknown), Scott A. Soefje, Ediz S. Calay, Yi Lin, Rafaël Fonseca, Sikander Ailawadhi, Ricardo Parrondo, Dee Lin, Bingcao Wu, Eli Silvert, Nina Kim, (unknown), (unknown), (unknown), Laura Hester, Alexander Mclean Marshall, Patrick Stoy, Dina Gifkins, Shaji Kumar	6
6	HSD34 Treatment Patterns and Healthcare-Resource Utilization Among Chronic Rhinosinusitis with Nasal Polyps Patients: In the New Era of Biologics 2022 ·Value in Health ·Lei Jin, Lei Ai, (unknown), (unknown), (unknown), (unknown), (unknown), Mitchell K. Higashi, Tomi Jun, William Oh, Ediz S. Calay, Radoslav Savić, (unknown), Andrew Kasarskis, (unknown), Gustavo Stolovitzky, (unknown), (unknown), (unknown)	1
7	Phenotypic and endotypic features of COPD associated with lung cancer development. 2022 ·Journal of Clinical Oncology ·(unknown), (unknown), Zongzhi Liu, Lei Ai, (unknown), (unknown), (unknown), Minghao Li, Xingmin Zhang, Tomi Jun, Mitchell K. Higashi, William Oh, Ediz S. Calay, Radoslav Savić, (unknown), Andrew Kasarskis, Tommy Mullaney, (unknown), Eric E. Schadt, Xiaoyan Wang	1
8	Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism 2021 ·Cell Metabolism ·Amir Tirosh, Gürol Tuncman, Ediz S. Calay, M. Rathaus, Idit Ron, Amit Tirosh, Abdullah Yalçın, (unknown), (unknown), (unknown), Neri Minsky, Ana Paula Arruda, Gökhan S. Hotamışlıgil	14
9	A hormone complex of FABP4 and nucleoside kinases regulates islet function 2021 ·Nature ·Kacey J. Prentice, Jani Saksi, Lauren Robertson, (unknown), Karen Inouye, Kosei Eguchi, Alexandra Lee, Özgür Çakıcı, (unknown), (unknown), Peter Achenbach, Anette‐Gabriele Ziegler, Ediz S. Calay, Feyza Engin, Gökhan S. Hotamışlıgil	61
10	Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism 2020 ·Cell Metabolism ·Amir Tirosh, (unknown), Gürol Tuncman, Ediz S. Calay, M. Rathaus, Idit Ron, Amit Tirosh, Abdullah Yalçın, (unknown), (unknown), (unknown), Neri Minsky, Ana Paula Arruda, Gökhan S. Hotamışlıgil	75
11	The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans 2019 ·Science Translational Medicine ·Amir Tirosh, Ediz S. Calay, Gürol Tuncman, Kathryn Claiborn, Karen Inouye, Kosei Eguchi, (unknown), M. Rathaus, (unknown), Idit Ron, (unknown), Yoriko Heianza, Lu Qi, Iris Shai, Rajesh Garg, Gökhan S. Hotamışlıgil	209
12	S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction 2015 ·Science ·Ling Yang, Ediz S. Calay, Jason Fan, Alessandro Arduini, Ryan C. Kunz, Steven P. Gygi, Abdullah Yalçın, Suneng Fu, Gökhan S. Hotamışlıgil	186
13	Dietary restriction protects against experimental cerebral malaria via leptin modulation and T-cell mTORC1 suppression 2015 ·Nature Communications ·Pedro Mejia, J. Humberto Treviño-Villarreal, Christopher Hine, Eylul Harputlugil, Samantha Lang, Ediz S. Calay, (unknown), Dyann F. Wirth, Manoj T. Duraisingh, James R. Mitchell	58
14	Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes 2015 ·Science Translational Medicine ·M. Furkan Burak, Karen Inouye, (unknown), Alexandra Lee, Gürol Tuncman, Ediz S. Calay, Motohiro Sekiya, Amir Tirosh, Kosei Eguchi, Gabriel Birrane, Daniel Lightwood, (unknown), (unknown), Hanna Hailu, Shauna West, Rachel A. Garlish, (unknown), Carl Doyle, Adrian Moore, Gökhan S. Hotamışlıgil	73
15	Stamp2 Controls Macrophage Inflammation through Nicotinamide Adenine Dinucleotide Phosphate Homeostasis and Protects against Atherosclerosis 2012 ·Cell Metabolism ·(unknown), Ediz S. Calay, Abdullah Yalçın, Sara N. Vallerie, Ling Yang, (unknown), Fahri Saatcioglu, Gökhan S. Hotamisligil	41
16	Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance breakdown → 2010 ·Cell Metabolism ·Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamışlıgil	1015
17	Sandwich-type, antibody microarrays for the detection and quantification of cardiovascular risk markers 2007 ·Sensors and Actuators B Chemical ·Özgür Gül, Ediz S. Calay, Osman Uğur Sezerman, Hüveyda Başağa, Yaşar Gürbüz	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact